Literature DB >> 21377364

Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt?

Robin B Fitzsimons1.   

Abstract

The peripheral retinal vascular abnormality which accompanies FSHD belongs morphologically and clinically to a class of developmental 'retinal hypovasculopathies' caused by abnormalities of 'Wnt' signalling, which controls retinal angiogenesis. Wnt signalling is also fundamental to myogenesis. This paper integrates modern concepts of myogenic cell signalling and of transcription factor expression and control with data from the classic early ophthalmic and myology embryology literature. Together, they support an hypothesis that abnormalities of Wnt signalling, which activates myogenic programs and transcription factors in myoblasts and satellite cells, leads to defective muscle regeneration in FSHD. The selective vulnerability of different FSHD muscles (notably facial muscle, from the second branchial arch) might reflect patterns of transcription factor redundancies. This hypothesis has implications for FSHD research through study of transcription factors patterning in normal human muscles, and for autologous cell transplantation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377364     DOI: 10.1016/j.nmd.2011.02.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  21 in total

1.  Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.

Authors:  Gregory J Block; Divya Narayanan; Amanda M Amell; Lisa M Petek; Kathryn C Davidson; Thomas D Bird; Rabi Tawil; Randall T Moon; Daniel G Miller
Journal:  Hum Mol Genet       Date:  2013-07-02       Impact factor: 6.150

2.  Dynamic transcriptomic analysis reveals suppression of PGC1α/ERRα drives perturbed myogenesis in facioscapulohumeral muscular dystrophy.

Authors:  Christopher R S Banerji; Maryna Panamarova; Johanna Pruller; Nicolas Figeac; Husam Hebaishi; Efthymios Fidanis; Alka Saxena; Julian Contet; Sabrina Sacconi; Simone Severini; Peter S Zammit
Journal:  Hum Mol Genet       Date:  2019-04-15       Impact factor: 6.150

3.  Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers.

Authors:  Fedik Rahimov; Oliver D King; Doris G Leung; Genila M Bibat; Charles P Emerson; Louis M Kunkel; Kathryn R Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

Review 4.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

Review 5.  Deciphering transcription dysregulation in FSH muscular dystrophy.

Authors:  Melanie Ehrlich; Michelle Lacey
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

6.  β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.

Authors:  Christopher R S Banerji; Paul Knopp; Louise A Moyle; Simone Severini; Richard W Orrell; Andrew E Teschendorff; Peter S Zammit
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

7.  Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy.

Authors:  Nathalie Caruso; Balàzs Herberth; Marc Bartoli; Francesca Puppo; Julie Dumonceaux; Angela Zimmermann; Simon Denadai; Marie Lebossé; Stephane Roche; Linda Geng; Frederique Magdinier; Shahram Attarian; Rafaelle Bernard; Flavio Maina; Nicolas Levy; Françoise Helmbacher
Journal:  PLoS Genet       Date:  2013-06-13       Impact factor: 5.917

8.  Gene expression during normal and FSHD myogenesis.

Authors:  Koji Tsumagari; Shao-Chi Chang; Michelle Lacey; Carl Baribault; Sridar V Chittur; Janet Sowden; Rabi Tawil; Gregory E Crawford; Melanie Ehrlich
Journal:  BMC Med Genomics       Date:  2011-09-27       Impact factor: 3.063

Review 9.  Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals.

Authors:  Ceren Hangül; Sibel Berker Karaüzüm; Esra Küpeli Akkol; Devrim Demir-Dora; Zafer Çetin; Eyüp İlker Saygılı; Gökhan Evcili; Eduardo Sobarzo-Sánchez
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

10.  Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.

Authors:  Yvonne D Krom; Peter E Thijssen; Janet M Young; Bianca den Hamer; Judit Balog; Zizhen Yao; Lisa Maves; Lauren Snider; Paul Knopp; Peter S Zammit; Tonnie Rijkers; Baziel G M van Engelen; George W Padberg; Rune R Frants; Rabi Tawil; Stephen J Tapscott; Silvère M van der Maarel
Journal:  PLoS Genet       Date:  2013-04-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.